Literature DB >> 32563027

Designing a tablet-based prematurity education app for parents hospitalized for preterm birth.

Nicole M Rau1, Kamrul Hasan2, Sheikh Iqbal Ahamed2, Onur Asan3, Kathryn E Flynn3, Mir A Basir4.   

Abstract

BACKGROUND: As technology has advanced over the last decade, handheld Mobile Health (mHealth) applications have increased in popularity. Pregnancy is one area of mHealth that has rapidly expanded, however very few pregnancy apps are developed in collaboration with health professionals. This creates an environment where the pregnancy information women are accessing may be inaccurate or even dangerous. Additionally, there are relatively few medical apps devoted to prematurity or targeted to women at risk for premature birth. To address the gap in premature birth education, we assembled a multidisciplinary team, including health care professionals, and developed the Preemie Prep for Parents (P3) app.
METHODS: Our team previously conducted 5 focus group meetings to assess the information needs of our target audience. Based on this information we developed a low fidelity P3 prototype. Our software development team transferred the low fidelity prototype into a high fidelity prototype which was hosted on Test Flight (a beta testing platform). We performed heuristic evaluation as well as user testing to improve the P3 app.
RESULTS: User testing of the high fidelity P3 prototype was performed with 13 diverse participants. 6 participants were parents of currently admitted Neonatal Intensive Care Unit (NICU) babies and 7 participants were women who had been or were currently pregnant. The native language of participants included English, Spanish, and Hmong and their educational level varied between completing high school and graduate degree. Participants provided feedback on the content of the P3 app, as well as its organization and aesthetics. The feedback led to 83 iterations of the P3 app prior to its deployment. Overall, participants noted that the information was "informative" and "reliable". They also noted that the P3 app provided control over the information they could view and when they viewed it, stating "I could see info on my time". Overall, participants felt that the P3 app was a valuable tool for mothers in preterm labor and it would help them ask questions.
CONCLUSIONS: Development of a mHealth app provides unique challenges regarding content, reliability of information, organization, and aesthetics. Creation of the P3 app to address the educational needs of women at risk for premature birth required assembling a multidisciplinary team, which included target users, and implementing an iterative design process. The efficacy of this app in improving user knowledge and decreasing anxiety is currently being tested in a randomized controlled trial.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mobile applications; Mobile health; Patient education; Pregnancy; Premature birth; Telemedicine

Mesh:

Year:  2020        PMID: 32563027     DOI: 10.1016/j.ijmedinf.2020.104200

Source DB:  PubMed          Journal:  Int J Med Inform        ISSN: 1386-5056            Impact factor:   4.046


  3 in total

1.  A Veteran-Centric Web-Based Decision Aid for Lung Cancer Screening: Usability Analysis.

Authors:  Marilyn M Schapira; Sumedha Chhatre; Jason M Prigge; Jessica Meline; Dana Kaminstein; Keri L Rodriguez; Liana Fraenkel; Jeffrey D Kravetz; Jeff Whittle; Lori A Bastian; Anil Vachani; Scott Akers; Susan Schrand; Jennifer V Ibarra; Onur Asan
Journal:  JMIR Form Res       Date:  2022-04-08

2.  Development of a mobile application focusing on developmental support care for Korean infants born prematurely: a methodological study.

Authors:  Ji Hyeon Park; Haeryun Cho
Journal:  Child Health Nurs Res       Date:  2022-04-30

Review 3.  Technology-Based Approaches for Supporting Perinatal Mental Health.

Authors:  Andrew M Novick; Melissa Kwitowski; Jack Dempsey; Danielle L Cooke; Allison G Dempsey
Journal:  Curr Psychiatry Rep       Date:  2022-07-23       Impact factor: 8.081

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.